HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 11-MAY-18 6DE5 TITLE MYCOBACTERIUM TUBERCULOSIS RV2671 COMPLEXED WITH BETA-NADPH AND 6- TITLE 2 ETHYL-5-{(3S)-3-[2-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- TITLE 3 YL}PYRIMIDINE-2,4-DIAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBOFLAVIN BIOSYNTHESIS PROTEIN RIBD; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS (STRAIN ATCC 25618 / SOURCE 3 H37RV); SOURCE 4 ORGANISM_TAXID: 83332; SOURCE 5 STRAIN: ATCC 25618 / H37RV; SOURCE 6 GENE: RIBD, RV2671; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DHFR, ANTIFOLATES, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.HAJIAN,D.WRIGHT REVDAT 4 11-OCT-23 6DE5 1 REMARK REVDAT 3 18-DEC-19 6DE5 1 REMARK REVDAT 2 10-JUL-19 6DE5 1 JRNL REVDAT 1 23-MAY-18 6DE5 0 JRNL AUTH B.HAJIAN,E.SCOCCHERA,C.SHOEN,J.KRUCINSKA,K.VISWANATHAN, JRNL AUTH 2 N.G-DAYANANDAN,H.ERLANDSEN,A.ESTRADA,K.MIKUSOVA, JRNL AUTH 3 J.KORDULAKOVA,M.CYNAMON,D.WRIGHT JRNL TITL DRUGGING THE FOLATE PATHWAY IN MYCOBACTERIUM TUBERCULOSIS: JRNL TITL 2 THE ROLE OF MULTI-TARGETING AGENTS. JRNL REF CELL CHEM BIOL V. 26 781 2019 JRNL REFN ESSN 2451-9456 JRNL PMID 30930162 JRNL DOI 10.1016/J.CHEMBIOL.2019.02.013 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 11313 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1132 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 56.5216 - 4.5996 0.97 1338 149 0.1642 0.1734 REMARK 3 2 4.5996 - 3.6511 0.98 1289 143 0.1476 0.1977 REMARK 3 3 3.6511 - 3.1896 0.99 1281 143 0.1874 0.2871 REMARK 3 4 3.1896 - 2.8980 0.98 1275 141 0.2090 0.2946 REMARK 3 5 2.8980 - 2.6903 0.97 1227 137 0.2261 0.2828 REMARK 3 6 2.6903 - 2.5317 0.99 1269 140 0.2204 0.2799 REMARK 3 7 2.5317 - 2.4049 0.97 1250 140 0.2242 0.3388 REMARK 3 8 2.4049 - 2.3002 0.98 1252 139 0.2180 0.3068 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.540 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 1967 REMARK 3 ANGLE : 1.236 2685 REMARK 3 CHIRALITY : 0.043 316 REMARK 3 PLANARITY : 0.005 343 REMARK 3 DIHEDRAL : 14.615 713 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DE5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1000234470. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-OCT-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X17B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11313 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 56.505 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09100 REMARK 200 FOR THE DATA SET : 5.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.23600 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 4XT7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1-0.3 M NACLI, 0.1M BIS-TRIS PH 5.5 REMARK 280 -7.5, 20-30% PEG 3350, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.75000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.75000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.22000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.31550 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.22000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.31550 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.75000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.22000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.31550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 37.75000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.22000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.31550 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 434 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 ASP A 3 REMARK 465 SER A 4 REMARK 465 GLY A 5 REMARK 465 GLN A 6 REMARK 465 LEU A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 ALA A 10 REMARK 465 ASP A 11 REMARK 465 THR A 12 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 97 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O7N NDP A 301 O HOH A 401 2.13 REMARK 500 O GLY A 57 O2D NDP A 301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 50 31.41 -99.75 REMARK 500 GLU A 91 -50.66 -20.94 REMARK 500 ASP A 129 78.65 -102.50 REMARK 500 LEU A 187 59.25 -108.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NDP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G8J A 302 DBREF 6DE5 A 1 258 UNP P71968 P71968_MYCTU 1 258 SEQRES 1 A 258 MET PRO ASP SER GLY GLN LEU GLY ALA ALA ASP THR PRO SEQRES 2 A 258 LEU ARG LEU LEU SER SER VAL HIS TYR LEU THR ASP GLY SEQRES 3 A 258 GLU LEU PRO GLN LEU TYR ASP TYR PRO ASP ASP GLY THR SEQRES 4 A 258 TRP LEU ARG ALA ASN PHE ILE SER SER LEU ASP GLY GLY SEQRES 5 A 258 ALA THR VAL ASP GLY THR SER GLY ALA MET ALA GLY PRO SEQRES 6 A 258 GLY ASP ARG PHE VAL PHE ASN LEU LEU ARG GLU LEU ALA SEQRES 7 A 258 ASP VAL ILE VAL VAL GLY VAL GLY THR VAL ARG ILE GLU SEQRES 8 A 258 GLY TYR SER GLY VAL ARG MET GLY VAL VAL GLN ARG GLN SEQRES 9 A 258 HIS ARG GLN ALA ARG GLY GLN SER GLU VAL PRO GLN LEU SEQRES 10 A 258 ALA ILE VAL THR ARG SER GLY ARG LEU ASP ARG ASP MET SEQRES 11 A 258 ALA VAL PHE THR ARG THR GLU MET ALA PRO LEU VAL LEU SEQRES 12 A 258 THR THR THR ALA VAL ALA ASP ASP THR ARG GLN ARG LEU SEQRES 13 A 258 ALA GLY LEU ALA GLU VAL ILE ALA CYS SER GLY ASP ASP SEQRES 14 A 258 PRO GLY THR VAL ASP GLU ALA VAL LEU VAL SER GLN LEU SEQRES 15 A 258 ALA ALA ARG GLY LEU ARG ARG ILE LEU THR GLU GLY GLY SEQRES 16 A 258 PRO THR LEU LEU GLY THR PHE VAL GLU ARG ASP VAL LEU SEQRES 17 A 258 ASP GLU LEU CYS LEU THR ILE ALA PRO TYR VAL VAL GLY SEQRES 18 A 258 GLY LEU ALA ARG ARG ILE VAL THR GLY PRO GLY GLN VAL SEQRES 19 A 258 LEU THR ARG MET ARG CYS ALA HIS VAL LEU THR ASP ASP SEQRES 20 A 258 SER GLY TYR LEU TYR THR ARG TYR VAL LYS THR HET NDP A 301 48 HET G8J A 302 28 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM G8J 6-ETHYL-5-{(3S)-3-[2-METHOXY-5-(PYRIDIN-4-YL) HETNAM 2 G8J PHENYL]BUT-1-YN-1-YL}PYRIMIDINE-2,4-DIAMINE FORMUL 2 NDP C21 H30 N7 O17 P3 FORMUL 3 G8J C22 H23 N5 O FORMUL 4 HOH *35(H2 O) HELIX 1 AA1 GLY A 26 TYR A 32 1 7 HELIX 2 AA2 GLY A 64 ALA A 78 1 15 HELIX 3 AA3 VAL A 85 ARG A 89 1 5 HELIX 4 AA4 GLY A 99 ARG A 109 1 11 HELIX 5 AA5 MET A 130 ARG A 135 1 6 HELIX 6 AA6 THR A 145 LEU A 156 1 12 HELIX 7 AA7 ASP A 174 ARG A 185 1 12 HELIX 8 AA8 GLY A 195 ARG A 205 1 11 SHEET 1 AA1 9 GLU A 161 ALA A 164 0 SHEET 2 AA1 9 LEU A 141 THR A 144 1 N VAL A 142 O ILE A 163 SHEET 3 AA1 9 GLN A 116 VAL A 120 1 N LEU A 117 O LEU A 141 SHEET 4 AA1 9 VAL A 80 GLY A 84 1 N ILE A 81 O ALA A 118 SHEET 5 AA1 9 ARG A 189 THR A 192 1 O LEU A 191 N VAL A 82 SHEET 6 AA1 9 TRP A 40 SER A 48 1 N ASN A 44 O THR A 192 SHEET 7 AA1 9 GLU A 210 ALA A 216 1 O CYS A 212 N ALA A 43 SHEET 8 AA1 9 LEU A 251 LYS A 257 -1 O LEU A 251 N ILE A 215 SHEET 9 AA1 9 MET A 238 THR A 245 -1 N ARG A 239 O VAL A 256 CISPEP 1 GLY A 194 GLY A 195 0 -0.16 CISPEP 2 LYS A 257 THR A 258 0 11.78 SITE 1 AC1 22 PHE A 45 ALA A 53 THR A 54 GLY A 57 SITE 2 AC1 22 SER A 59 GLY A 84 VAL A 85 GLY A 86 SITE 3 AC1 22 THR A 87 VAL A 120 THR A 121 ARG A 122 SITE 4 AC1 22 SER A 123 GLU A 175 GLY A 195 PRO A 196 SITE 5 AC1 22 THR A 197 LEU A 198 THR A 201 ARG A 225 SITE 6 AC1 22 HOH A 401 HOH A 433 SITE 1 AC2 9 ASN A 44 PHE A 45 ILE A 46 SER A 59 SITE 2 AC2 9 ASP A 67 ARG A 68 PHE A 71 GLU A 193 SITE 3 AC2 9 THR A 214 CRYST1 70.440 94.631 75.500 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014196 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010567 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013245 0.00000